BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9219844)

  • 1. Characterization of a cAMP-dependent protein kinase mutant resistant to cisplatin.
    Cvijic ME; Chin KV
    Int J Cancer; 1997 Jul; 72(2):345-50. PubMed ID: 9219844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin resistance and regulation of DNA repair in cAMP-dependent protein kinase mutants.
    Liu B; Cvijic ME; Jetzt A; Chin KV
    Cell Growth Differ; 1996 Aug; 7(8):1105-12. PubMed ID: 8853907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of P-glycoprotein expression in cyclic AMP-dependent protein kinase mutants.
    Cvijic ME; Chin KV
    Cell Growth Differ; 1997 Dec; 8(12):1243-7. PubMed ID: 9419412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of RIalpha overexpression on cisplatin sensitivity in human ovarian carcinoma cells.
    Cvijic ME; Chin KV
    Biochem Biophys Res Commun; 1998 Aug; 249(3):723-7. PubMed ID: 9731205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin sensitivity in cAMP-dependent protein kinase mutants of Saccharomyces cerevisiae.
    Cvijic ME; Yang WL; Chin KV
    Anticancer Res; 1998; 18(5A):3187-92. PubMed ID: 9858882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin resistance in cyclic AMP-dependent protein kinase mutants.
    Cvijic ME; Yang WL; Chin KV
    Pharmacol Ther; 1998 May; 78(2):115-28. PubMed ID: 9623882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of modulation of MDR1 gene expression by dominant inhibition of cAMP-dependent protein kinase in doxorubicin-resistant MCF-7 breast cancer cells.
    Parissenti AM; Gannon BR; Villeneuve DJ; Kirwan-rhude AF; Chadderton A; Glück S
    Int J Cancer; 1999 Sep; 82(6):893-900. PubMed ID: 10446459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered regulation of the D(1) dopamine receptor in mutant Chinese hamster ovary cells deficient in cyclic AMP-dependent protein kinase activity.
    Ventura AL; Sibley DR
    J Pharmacol Exp Ther; 2000 May; 293(2):426-34. PubMed ID: 10773012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low expression of lipid-linked oligosaccharide due to a functionally altered Dol-P-Man synthase reduces protein glycosylation in cAMP-dependent protein kinase deficient Chinese hamster ovary cells.
    Banerjee DK; Aponte E; Dasilva JJ
    Glycoconj J; 2004; 21(8-9):479-86. PubMed ID: 15750789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial expression of Chinese hamster regulatory type-I and catalytic subunits of cyclic AMP-dependent protein kinase and mutational analysis of the type-I regulatory subunit.
    Gosse ME; Fleischmann R; Marshall M; Wang N; Garges S; Gottesman MM
    Biochem J; 1994 Jan; 297 ( Pt 1)(Pt 1):79-85. PubMed ID: 8280113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms determining sensitivity to cisplatin in three mutant Chinese hamster ovary cell lines.
    Segelov E; Mann G; deFazio A; Harnett PR
    Mutat Res; 1998 Jun; 407(3):243-52. PubMed ID: 9653450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfection of a mutant regulatory subunit gene of cAMP-dependent protein kinase causes increased drug sensitivity and decreased expression of P-glycoprotein.
    Abraham I; Chin KV; Gottesman MM; Mayo JK; Sampson KE
    Exp Cell Res; 1990 Jul; 189(1):133-41. PubMed ID: 1971796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel function of the regulatory subunit of protein kinase A: regulation of cytochrome c oxidase activity and cytochrome c release.
    Yang WL; Iacono L; Tang WM; Chin KV
    Biochemistry; 1998 Oct; 37(40):14175-80. PubMed ID: 9760254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the RI alpha subunit of protein kinase A confers hypersensitivity to topoisomerase II inhibitors and 8-chloro-cyclic adenosine 3'5'-monophosphate in Chinese hamster ovary cells.
    North PS; Davies SL; Ciardiello F; Damiano V; Bianco C; Pepe S; Bianco AR; Harris AL; Hickson ID; Tortora G
    Cancer Res; 1994 Aug; 54(15):4123-8. PubMed ID: 7518350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of protein kinase A - RIalpha reduces lipofection efficiency of cisplatin-resistant human tumor cells.
    Son KK; Rosenblatt J
    Cancer Lett; 2001 Apr; 165(1):81-6. PubMed ID: 11248422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic AMP (cAMP) confers drug resistance against DNA damaging agents via PKAIA in CML cells.
    Xiao LY; Kan WM
    Eur J Pharmacol; 2017 Jan; 794():201-208. PubMed ID: 27894809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-proliferative effects of 8-chloro-cAMP and other cAMP analogs are unrelated to their effects on protein kinase A regulatory subunit expression.
    Lamb D; Steinberg RA
    J Cell Physiol; 2002 Aug; 192(2):216-24. PubMed ID: 12115728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of glutathione S-transferase gene in cis-diamminedichloroplatinum(II)-resistant variants of a Chinese hamster ovary cell line.
    Saburi Y; Nakagawa M; Ono M; Sakai M; Muramatsu M; Kohno K; Kuwano M
    Cancer Res; 1989 Dec; 49(24 Pt 1):7020-5. PubMed ID: 2479474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular catalytic subunit activity of the cAMP-dependent protein kinase in prostate cancer.
    Cvijic ME; Kita T; Shih W; DiPaola RS; Chin KV
    Clin Cancer Res; 2000 Jun; 6(6):2309-17. PubMed ID: 10873081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of radiation-induced cisplatin resistance in murine fibrosarcoma cells by selective modulation of the cyclic GMP-dependent transduction pathway.
    Eichholtz-Wirth H
    Br J Cancer; 1995 Aug; 72(2):287-92. PubMed ID: 7640207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.